Effects of three different iron supplementations in term healthy infants after 5 months of life

The aim of this study was to investigate the effects of different doses of iron on haematological status of breastfed infants. One hundred and thirteen infants were randomized into four groups at 5 months of age. Iron supplementation was given at doses of 1 mg/kg/day, 2 mg/kg/day, and 2 mg/kg/every other day in the first three study groups, respectively, and the last group received placebo. The hematological values, except hemoglobin, were higher in the group supplemented with iron at a dose of 2 mg/kg/day, and ferritin values were statistically higher in the group supplemented with iron at a dose of 2 mg/kg/every other day than in the group supplemented with iron at a dose of 1 mg/kg/day. We suggest that intermittent iron supplementation is more effective than a daily regimen in equal dosages.

Yazar Ermis, B
Demirel, F
Demircan, N
Gurel, A
Yayın Türü Article
Tek Biçim Adres https://hdl.handle.net/20.500.12628/2516
Tek Biçim Adres 10.1093/tropej/48.5.280
Koleksiyonlar Araştırma Çıktıları | WoS | Scopus | TR-Dizin | PubMed | SOBİAD
PubMed İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu
Dergi Adı JOURNAL OF TROPICAL PEDIATRICS
Dergi Cilt Bilgisi 48
Dergi Sayısı 5
Sayfalar 280 - 284
Yayın Yılı 2002
Eser Adı
[dc.title]
Effects of three different iron supplementations in term healthy infants after 5 months of life
Yazar
[dc.contributor.author]
Ermis, B
Yazar
[dc.contributor.author]
Demirel, F
Yazar
[dc.contributor.author]
Demircan, N
Yazar
[dc.contributor.author]
Gurel, A
Yayın Yılı
[dc.date.issued]
2002
Yayıncı
[dc.publisher]
OXFORD UNIV PRESS
Yayın Türü
[dc.type]
article
Özet
[dc.description.abstract]
The aim of this study was to investigate the effects of different doses of iron on haematological status of breastfed infants. One hundred and thirteen infants were randomized into four groups at 5 months of age. Iron supplementation was given at doses of 1 mg/kg/day, 2 mg/kg/day, and 2 mg/kg/every other day in the first three study groups, respectively, and the last group received placebo. The hematological values, except hemoglobin, were higher in the group supplemented with iron at a dose of 2 mg/kg/day, and ferritin values were statistically higher in the group supplemented with iron at a dose of 2 mg/kg/every other day than in the group supplemented with iron at a dose of 1 mg/kg/day. We suggest that intermittent iron supplementation is more effective than a daily regimen in equal dosages.
Açıklama
[dc.description]
WOS: 000178120600006
Açıklama
[dc.description]
PubMed: 12405170
Kayıt Giriş Tarihi
[dc.date.accessioned]
2019-12-23
Açık Erişim Tarihi
[dc.date.available]
2019-12-23
Yayın Dili
[dc.language.iso]
eng
Haklar
[dc.rights]
info:eu-repo/semantics/openAccess
ISSN
[dc.identifier.issn]
0142-6338
ISSN
[dc.identifier.issn]
1465-3664
İlk Sayfa Sayısı
[dc.identifier.startpage]
280
Son Sayfa Sayısı
[dc.identifier.endpage]
284
Dergi Adı
[dc.relation.journal]
JOURNAL OF TROPICAL PEDIATRICS
Dergi Sayısı
[dc.identifier.issue]
5
Dergi Cilt Bilgisi
[dc.identifier.volume]
48
Tek Biçim Adres
[dc.identifier.uri]
https://dx.doi.org/10.1093/tropej/48.5.280
Tek Biçim Adres
[dc.identifier.uri]
https://hdl.handle.net/20.500.12628/2516
Görüntülenme Sayısı ( Şehir )
Görüntülenme Sayısı ( Ülke )
Görüntülenme Sayısı ( Zaman Dağılımı )
Görüntülenme
7
09.12.2022 tarihinden bu yana
İndirme
1
09.12.2022 tarihinden bu yana
Son Erişim Tarihi
18 Ocak 2024 04:52
Google Kontrol
Tıklayınız
mg/kg/day supplemented values higher groups mg/kg/every supplementation infants effects investigate ferritin statistically except suggest intermittent effective regimen dosages hemoglobin hematological different randomized thirteen months hundred breastfed status haematological respectively received placebo
6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve çerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms